A comprehensive view of regeneron pharmaceuticals inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

US Patent Issued to REGENERON PHARMACEUTICALS on April 23 for "Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy" (New York Inventors)
Published: April 24, 2024 by U.S. Fed News
US Patent Issued to Regeneron Pharmaceuticals on April 23 for "Humanized IL-4 and IL-4RAlpha animals" (New York, California Inventors)
Published: April 24, 2024 by U.S. Fed News
US Patent Issued to Regeneron Pharmaceuticals on April 23 for "Antigen binding molecule formats" (New York Inventors)
Published: April 24, 2024 by U.S. Fed News
US Patent Issued to Regeneron Pharmaceuticals on April 23 for "Perfusion bioreactor and related methods of use" (New York Inventors)
Published: April 24, 2024 by U.S. Fed News
US Patent Issued to Regeneron Pharmaceuticals on April 23 for "Retainer adapter assembly" (New York Inventors)
Published: April 24, 2024 by U.S. Fed News

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count